Cargando…

Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin

Cisplatin is an effective breast cancer drug but resistance often develops over prolonged chemotherapy. Therefore, we performed a candidate approach RNAi screen in combination with cisplatin treatment to identify molecular pathways conferring survival advantages. The screen identified ATP7A as a the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chisholm, Cristine L., Wang, Haitao, Wong, Ada Hang-Heng, Vazquez-Ortiz, Guelaguetza, Chen, Weiping, Xu, Xiaoling, Deng, Chu-Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341295/ https://www.ncbi.nlm.nih.gov/pubmed/27806319 http://dx.doi.org/10.18632/oncotarget.12992

Ejemplares similares

Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019)

Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma
por: Ryumon, Shoji, et al.
Publicado: (2019)

The copper chelator ammonium tetrathiomolybdate inhibits the progression of experimental endometriosis in TNFR1-deficient mice
por: Conforti, Rocío Ayelem, et al.
Publicado: (2023)

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
por: Li, Xiang, et al.
Publicado: (2020)

Analyzing the Therapeutic Efficacy of Bis-Choline-Tetrathiomolybdate in the Atp7b(−/−) Copper Overload Mouse Model
por: Kim, Philipp, et al.
Publicado: (2021)

Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
por: Zhang, Mengling, et al.
Publicado: (2022)

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series
por: De Fabregues, Oriol, et al.
Publicado: (2020)

Bis-choline tetrathiomolybdate prevents copper-induced blood–brain barrier damage
por: Borchard, Sabine, et al.
Publicado: (2021)

Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020)

Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats
por: Omoto, Atsushi, et al.
Publicado: (2005)

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers
por: Kim, Kyu Kwang, et al.
Publicado: (2015)

A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance
por: Zhu, Sha, et al.
Publicado: (2017)

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
por: Dyson, Alex, et al.
Publicado: (2017)

Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells
por: Vazquez-Ortiz, Guelaguetza, et al.
Publicado: (2014)

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
por: Liu, Ying L., et al.
Publicado: (2021)

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
por: Kalayda, Ganna V, et al.
Publicado: (2008)

Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H(2)O(2) generation: antagonism by tetrathiomolybdate
por: Calderon-Aparicio, Ali, et al.
Publicado: (2015)

Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
por: Fang, Tiantian, et al.
Publicado: (2019)

Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
por: Navrátilová, Jarmila, et al.
Publicado: (2017)

Structure of the Wilson disease copper transporter ATP7B
por: Bitter, Ryan M., et al.
Publicado: (2022)

Effects of ATP7A overexpression in mice on copper transport and metabolism in lactation and gestation
por: Wadwa, Jarrod, et al.
Publicado: (2014)

Tetrathiomolybdate Decreases the Expression of Alkaline Phosphatase in Dermal Papilla Cells by Increasing Mitochondrial ROS Production
por: Li, Fan, et al.
Publicado: (2023)

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel
por: Wang, Haitao, et al.
Publicado: (2021)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver?
por: Stremmel, Wolfgang
Publicado: (2018)

Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis
por: Derseh, Habtamu B., et al.
Publicado: (2021)

EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Abscisic acid influences ammonium transport via regulation of kinase CIPK23 and ammonium transporters
por: Ganz, Pascal, et al.
Publicado: (2022)

CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B
por: Pöhler, Michael, et al.
Publicado: (2020)

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008)

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
por: Kwang Kim, Kyu, et al.
Publicado: (2015)

Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors
por: Comstra, Heather S, et al.
Publicado: (2017)

Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells
por: Guttmann, Sarah, et al.
Publicado: (2017)

Evolution of Electrogenic Ammonium Transporters (AMTs)
por: McDonald, Tami R., et al.
Publicado: (2016)

Function and Regulation of Ammonium Transporters in Plants
por: Hao, Dong-Li, et al.
Publicado: (2020)

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
por: Kumar, Pawan, et al.
Publicado: (2010)

Evaluation of ATOX1 as a Potential Predictive Biomarker for Tetrathiomolybdate Treatment of Breast Cancer Patients with High Risk of Recurrence
por: Blockhuys, Stéphanie, et al.
Publicado: (2021)

Copper binding leads to increased dynamics in the regulatory N-terminal domain of full-length human copper transporter ATP7B
por: Orädd, Fredrik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mm70l2i2ufn8kgdjv7oe4nhtv3